Researchers are studying tailored treatments to improve prostate cancer care

NewsGuard 100/100 Score

Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.

© BlurryMe/Shutterstock.com

By developing treatment tailored to the specific needs of a particular individual, the researchers hope to extend lifespans, which they hope will be the case for 9,000 men each year.

Currently, men who have advanced prostate cancer are usually prescribed hormone therapy and when that stops being effective, they are moved onto life-extending treatments.

The study would lead to a shift from this “one size fits all” approach, to finding out which drugs will be most effective at treating the cancer, based on what is driving the disease in individual people.

"Every man's prostate cancer is unique to him and so not surprisingly the way men respond to treatments varies enormously,” explains Iain Frame, director of research at Prostate Cancer UK. “Clinicians are in effect left to treat patients 'in the dark' - with little idea as to which treatments will work best for which men."

The Glasgow researchers will collaborate with groups form London, Manchester and Belfast for the study, which has been launched by Prostate Cancer UK and will cost £1.4 million.

With more than 47,000 new cases diagnosed in the UK every year, prostate cancer is the most common form of cancer in men. About 25% of new cases are diagnosed after the cancer has spread from the prostate to other areas in the body, thereby reducing the likelihood of treatment being successful.

The research will initially look at men with advanced prostate cancer that can still be effectively managed with hormone therapy. The goal is to identify the changes in the DNA of prostate cancer cells so that a test can be developed to detect those changes. This will enable researchers to find out which drugs would best target the changes and prevent any further spread of the cancer. This approach is already used to treat women with advanced breast cancer.

Lead author of the study, Robert Jones, says: "It's already becoming clear in other common cancers, including cancers of the breast, lung and colon, that better outcomes can be achieved if we test the individual patient's tumour biology and then select the most appropriate treatment."

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 20). Researchers are studying tailored treatments to improve prostate cancer care. News-Medical. Retrieved on June 12, 2024 from https://www.news-medical.net/news/20171102/Researchers-are-studying-tailored-treatments-to-improve-prostate-cancer-care.aspx.

  • MLA

    Robertson, Sally. "Researchers are studying tailored treatments to improve prostate cancer care". News-Medical. 12 June 2024. <https://www.news-medical.net/news/20171102/Researchers-are-studying-tailored-treatments-to-improve-prostate-cancer-care.aspx>.

  • Chicago

    Robertson, Sally. "Researchers are studying tailored treatments to improve prostate cancer care". News-Medical. https://www.news-medical.net/news/20171102/Researchers-are-studying-tailored-treatments-to-improve-prostate-cancer-care.aspx. (accessed June 12, 2024).

  • Harvard

    Robertson, Sally. 2019. Researchers are studying tailored treatments to improve prostate cancer care. News-Medical, viewed 12 June 2024, https://www.news-medical.net/news/20171102/Researchers-are-studying-tailored-treatments-to-improve-prostate-cancer-care.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ultrasound technology breaks blood-brain barrier for glioblastoma treatment